The initial success of Viagra undeniably transformed the medication landscape, but investing in companies heavily reliant on off-patent versions presents a uncertain picture. Although early earnings were significant, the cessation of patents and the appearance of cheaper alternatives have diminished the customer base. Consequently, a thorough analy